German Opportunity Card for Skilled Migrants
18 June 2024 | The Study IASContext: On 1 June 2024, the German government released the third stage of its Skilled Immigration Act which introduced the...
Context: On 1 June 2024, the German government released the third stage of its Skilled Immigration Act which introduced the...
Context: According to a new report released by ICIMOD, snowfall reduction over the Indus, Ganga and Brahmaputra basins is expected...
What is a Zero-Knowledge Proof (ZKP)? A cryptographic method enabling one party (the prover) to convince another party (the verifier)...
Context: Brazil’s Pantanal wetland is experiencing unprecedented fires in June, setting a new record for this month. More on...
Context: Researchers at the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences have developed...
Context: Agricultural and Processed Food Products Export Development Authority (APEDA) facilitated first consignment of MD 2 pineapples to United Arab...
Context: A rare four-horned antelope has been sighted for the first time in Veerangana Durgavati Tiger Reserve (Sagar district). Four-horned...
Context: The United Nations has designated 24th May as the International Day of the Markhor to raise awareness about this...
Context: According to a recent study artificial sweeteners in chewing gum and even toothpaste can give you blood clots, heart...
Context: As the US prepares for the presidential election in November, the Federal Reserve has indicated that it is unwilling...
Context: A study published in Geophysical Research Letters reveals an 8-fold increase in aluminium oxides between 2016 and 2022 expected...
Context: The Indian Institute of Science Education and Research, Pune, is actively engaged in the development of a strontium optical...
Context: BRICS ministers, during their meeting in Russia, reaffirmed their commitment to ensuring the long-term sustainability of outer space activities...
Context: The cost of a short-stay Schengen visa has increased internationally by 12%, according to the European Commission. More...
Context: Donanemab, a new therapy for Alzheimer’s disease developed by drug maker Eli Lilly, has received unanimous support from independent...